Current opportunities
The companies profiled are some of the investment opportunities
currently available in New Zealand. Please note that these
opportunities are not endorsed or recommended by New Zealand Trade
and Enterprise (NZTE), and may be updated from time to time.
Investors are advised to contact our New Zealand-based
investment specialist to discuss further.
AFT Pharmaceuticals sells over the counter and prescription products, and also undertakes drug development activities including clinical trials.
BLIS Technologies develops, manufactures and sells advanced probiotics.
CoDa Therapeutics Inc. is a biopharmaceutical company developing and commercializing a new generation of wound care and tissue repair therapeutics.
Graftoss is developing an orthopedic device which has bone graft and bone replacement applications.
Innate Therapeutics has designed and manufactured a unique immunomodulator microparticle technology to treat immune system disorders.
Izon is a New Zealand-based nanotechnology company which has developed instrumentation for nanoscale particle analysis.
KODE Biotech is a platform technology company which licenses its KODE™ technology to commercial and academic entities.
Living Cell Technologies (LCT) is a global pioneer in the development of revolutionary new living cell products for the treatment of diabetes, neurological disease and hemophilia.
Mesynthes is a regenerative medicine company focused on developing, manufacturing and supplying extracellular matrix based soft tissue regeneration devices for wound care and reconstructive plastic surgery.
Migco Pharmaceuticals is developing and commercializing new drug therapies for the prevention and treatment of migraine headaches.
